EFORT: Strontium ranelate treatment appears to improve tibial fracture healing .
Significance of P1NP values in assessment of fracture healing of surgically fixed tibial diapyseal fractures treated with strontium ranelate vs placebo: a randomised double blind controlled trial
69 patients with a surgically fixed closed diaphyseal tibial fracture were randomized to receive either strontium ranelate or a placebo. The purpose was to evaluate the effect of strontium ranelate on fracture healing and levels of procollagen N-terminal nucleopeptide (PINP). Results indicated a significant improvement in PINP levels from baseline to 90 days within the strontium ranelate group, although there was no between-group difference at 90 days. Overall rate of fracture healing was significantly higher in the strontium ranelate group compared to the placebo group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
